295 related articles for article (PubMed ID: 8635097)
61. Preoperative abdominopelvic computed tomographic prediction of optimal cytoreduction in epithelial ovarian carcinoma.
Nelson BE; Rosenfield AT; Schwartz PE
J Clin Oncol; 1993 Jan; 11(1):166-72. PubMed ID: 8418230
[TBL] [Abstract][Full Text] [Related]
62. OncoScint image atlas.
Maguire RT
Targeted Diagn Ther; 1992; 6():141-75. PubMed ID: 1576344
[No Abstract] [Full Text] [Related]
63. Indium-111 OncoScint CR/OV and F-18 FDG in colorectal and ovarian carcinoma recurrences. Early observations.
Bohdiewicz PJ; Scott GC; Juni JE; Fink-Bennett D; Wilner F; Nagle C; Dworkin HJ
Clin Nucl Med; 1995 Mar; 20(3):230-6. PubMed ID: 7750217
[TBL] [Abstract][Full Text] [Related]
64. Radioimmunoscintigraphy in patients with ovarian cancer.
Kalofonos HP; Giannakenas C; Kosmas C; Apostolopoulos D; Onienadum A; Petsas T; Dimopoulos D; Epenetos AA; Vassilakos PJ
Acta Oncol; 1999; 38(5):629-34. PubMed ID: 10427953
[TBL] [Abstract][Full Text] [Related]
65. Comparative study of RIS with the 131I-OC 125 F(ab')2 Mab and CT scan prior to second look operation for ovarian cancer.
Papazefkos V; Michalas S; Papantoniou V; Datseris J; Athanasiadis P; Akrivos T; Leonti A; Xygakis A; Aravantinos D
Eur J Obstet Gynecol Reprod Biol; 1990 Dec; 37(3):271-7. PubMed ID: 2227070
[TBL] [Abstract][Full Text] [Related]
66. Radioimmunodetection of colorectal carcinoma.
Artiko V; Obradovic V; Davidovic B; Petrovic N; Petrovic M; Krivokapic Z; Kecmanovic D; Pesko P; Djukic V; Milosavljevic T; Adanja G; Vlajkovic M
Hepatogastroenterology; 2003; 50(52):1029-31. PubMed ID: 12845972
[TBL] [Abstract][Full Text] [Related]
67. Role of In-111 labeled CYT-103 immunoscintigraphy in the evaluation of patients with recurrent colorectal carcinoma.
Markowitz A; Saleemi K; Freeman LM
Clin Nucl Med; 1993 Aug; 18(8):685-700. PubMed ID: 8403703
[TBL] [Abstract][Full Text] [Related]
68. Monoclonal antibody imaging of occult prostate cancer in patients with elevated prostate-specific antigen. Positron emission tomography and biopsy correlation.
Haseman MK; Reed NL; Rosenthal SA
Clin Nucl Med; 1996 Sep; 21(9):704-13. PubMed ID: 8879871
[TBL] [Abstract][Full Text] [Related]
69. Radioimmunoscintigraphy of colorectal carcinoma with a 111In-labelled anti-TAG-72 monoclonal antibody.
Muxí A; Pons F; Herranz R; Novell F; Fernández R; Filella X; García A; Solá M; Trías M; Setoain J
Nucl Med Commun; 1993 Sep; 14(9):775-87. PubMed ID: 8233243
[TBL] [Abstract][Full Text] [Related]
70. Radioimmunoscintigraphy of recurrent colorectal carcinoma using 111In-labelled murine monoclonal antibody B72.3: a comparison with contrast-enhanced computed tomography.
Kmiot WA; Stonelake P; Sagar G; Donovan IA; Neoptolemos JP; Notghi A; Harding LK
Nucl Med Commun; 1993 Sep; 14(9):788-91. PubMed ID: 8233244
[TBL] [Abstract][Full Text] [Related]
71. Impact of radioimmunoscintigraphy on the management of colorectal and ovarian cancer patients: a retrospective study.
Blend MJ; Bhadkamkar VA
Cancer Invest; 1998; 16(7):431-41. PubMed ID: 9774949
[TBL] [Abstract][Full Text] [Related]
72. Superimposition of computed tomography and single photon emission tomography immunoscintigraphic images in the pelvis: validation in patients with colorectal or ovarian carcinoma recurrence.
Liehn JC; Loboguerrero A; Pérault C; Demange L
Eur J Nucl Med; 1992; 19(3):186-94. PubMed ID: 1572383
[TBL] [Abstract][Full Text] [Related]
73. Planar, SPET and three-dimensional immunoscintigraphy of suspected recurrent colorectal cancer using 111In-B72.3 (Oncoscint CR-OV): effect of administered activity.
Perkins AC; Vincent RM; Wastie ML; Denton GW; Amar S; Hardcastle JD
Nucl Med Commun; 1994 Dec; 15(12):981-90. PubMed ID: 7715898
[TBL] [Abstract][Full Text] [Related]
74. Tumour detection and localization using 99Tcm-labelled OV-TL 3 Fab' in patients suspected of ovarian cancer.
Tibben JG; Massuger LF; Claessens RA; Schijf CP; Pak KY; Strijk SP; Kenemans P; Corstens FH
Nucl Med Commun; 1992 Dec; 13(12):885-93. PubMed ID: 1465272
[TBL] [Abstract][Full Text] [Related]
75. The role of second-look laparotomy in treatment of epithelial ovarian cancer.
McCusker MC; Hoffman JS; Curry SL; Koulos JP; Gondos B
Gynecol Oncol; 1987 Sep; 28(1):83-8. PubMed ID: 3653773
[TBL] [Abstract][Full Text] [Related]
76. The role of indium-111 radioimmunoscintigraphy in post-radical retropubic prostatectomy management of prostate cancer patients.
Jani AB; Liauw SL; Blend MJ
Clin Med Res; 2007 Jun; 5(2):123-31. PubMed ID: 17607048
[TBL] [Abstract][Full Text] [Related]
77. Multidrug resistance gene-1 (Pgp) expression in epithelial ovarian malignancies.
Ozalp SS; Yalcin OT; Tanir M; Kabukcuoglu S; Etiz E
Eur J Gynaecol Oncol; 2002; 23(4):337-40. PubMed ID: 12214739
[TBL] [Abstract][Full Text] [Related]
78. The value of CA 125 measurement before second-look laparotomy in patients with ovarian carcinoma.
Hørding U; Toftager-Larsen K; Lund B; Dreisler A; Daugaard S; Lundvall F; Knudsen JB; Bock JE
Eur J Gynaecol Oncol; 1994; 15(3):217-21. PubMed ID: 7957327
[TBL] [Abstract][Full Text] [Related]
79. The utility of computed tomography scans in predicting suboptimal cytoreductive surgery in women with advanced ovarian carcinoma.
Dowdy SC; Mullany SA; Brandt KR; Huppert BJ; Cliby WA
Cancer; 2004 Jul; 101(2):346-52. PubMed ID: 15241833
[TBL] [Abstract][Full Text] [Related]
80. Radioimmunodetection of ovarian cancer.
Ahlström KR; Hietala SO; Stendahl U; Stigbrand T
Acta Oncol; 1993; 32(7-8):729-34. PubMed ID: 8305219
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
